Scientific Presentations

Home OCT & Notal OCT Analyzer
Retina Festival Update 2021 | December 2021

Monitoring Patients for Neovascular AMD – At Office and Home

Anat Loewenstein, MD
2021 Robert Haimovici Visiting Retina Lecture | October 2021

Personalizing Wet AMD Management through a Novel Concept of Fluid Assessment

Judy E. Kim, MD

Click here to view the presentation.

ASRS 2021 Annual Meeting | October 2021

Prospective Longitudinal Study: Fluid Quantification From Daily Self-imaging With Home OCT in Neovascular Age-Related Macular Degeneration (NV-AMD)

Jeffrey Heier, MD
Retina Society 2021 Annual Meeting | October 2021

Characterization of Retinal AI-based Fluid Volume Trajectories From Self-imaging With A Home OCT System

Judy E. Kim, MD
Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition | February 2021

Home OCT Based Management of Neovascular AMD

Anat Loewenstein, MD

SCANLY Home OCT FDA Intended Use

SCANLY Home OCT has not been approved by FDA for use other than described in the following Intend Use: The Notal Vision Home Optical Coherence Tomography (OCT) System is an Artificial Intelligence (AI)-based Home Use device indicated for visualization of intraretinal and subretinal hypo-reflective spaces in a 10 by 10-degrees area centered on the point of fixation of eyes diagnosed with neovascular age-related macular degeneration (NV-AMD). In addition, it provides segmentation and an estimation of the volume of hypo-reflective spaces. The Notal Home OCT device is intended for imaging at home between regularly scheduled clinic assessments and not intended to be used to make treatment decisions or replace standard-of care regularly scheduled examinations and clinical testing as needed, including in-office imaging and assessments for changes in vision, by an ophthalmologist.

See also Warnings and Precautions.

ForeseeHome FDA Intended Use

ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

Media enquiries? Reach out to our Media Contact